Abstract:Rhizoma Coptidis, which is mainly originated from the rhizomes of Coptis chinensis, C. deltoidea, C. omeiensis and C. teeta, has been proved to possess a superior anti-diabetic effect in clinic. However, the metabolic characterization and the hypoglycemic ingredients among these Coptis species remain unclear. In this study, we employed an integrated strategy to screen the bioactive ingredients based on metabolomics and ligand fishing approaches. First, the ultra high-performance liquid chromatography coupled to quadruple time-of-flight tandem mass spectrometry (UHPLC-Q-TOF-MS/MS) was used for qualitative identification of four Coptis rhizomes. After prescreening by α-glucosidase inhibition assay, an affinity ultrafiltration system was constructed to fish out hypoglycemic ingredients from the fractions with superior activity, and verified by molecular docking on a virtual platform. The distribution of major compounds suggested the four Coptis rhizomes possess similar metabolic profiles, mainly including alkaloids and phenylpropanoids. Besides, eight compounds (magnoflorine, groenlandicine, jatrorrhizine, epiberberine, columbamine, coptisine, palmatine and berberine) from the n-butanol fraction were specifically bound to α-glucosidase, and considered as hypoglycemic ingredients of Rhizoma Coptidis. Molecular docking revealed that the inhibitors bound to α-glucosidase mainly by hydrophobic interaction, hydrogen bond interaction and π-π interaction. Summary, this research leads a more systematic and comprehensive study on metabolic characterization and hypoglycemic ingredients of Rhizoma Coptidis, which can provide a theoretical basis for the further clinical application.

Isolation of Jatrorrhizine and Epiberberine in Coptis Chinensis and Their in Vitro Hypoglycemic Effect

Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells

Pharmacokinetics and Metabolism of Jatrorrhizine, A Gastric Prokinetic Drug Candidate

Coptis Chinensis Inflorescence Ameliorates Hyperglycaemia in 3T3-L1 Preadipocyte and Streptozotocin-Induced Diabetic Mice

Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids from Rhizoma Coptidis in Hepg2 Cell and Diabetic Kk-Ay Mice

Preliminary evaluation of antihyperglycemic effect of Rhizoma Coptidis alkaloids and their structure-activity relationships

Effective Therapeutic Verification of Crocin I, Geniposide, and Gardenia (Gardenia jasminoides Ellis) on Type 2 Diabetes Mellitus In Vivo and In Vitro

Screening for potential alpha-Glucosidase inhibitors in Coptis chinensis franch extract using ultrafiltration LC-ESI-MSn

[Separation of Choline from Coptidis Rhizoma and Impact on Glucose Metabolism of Berberine in HepG2 Cells].

Effect of Ferulic Acid from Coptis Chinensis Franch on Hypoglycemic Acitivity of Berberine in Hep G2 Cells

Study on the glucose-lowering effect of polysaccharide constituents from Coptis chinensis Franch

On a New Target for Treating Diabetes by Alkaloids of Rhizoma Coptis-UCP2

Cell Extraction Combined with Off-Line Hplc for Screening Active Compounds from Coptis Chinensis

Determination of Protoberberine Alkaloids in Coptis chinensis by Microextraction and High Performance Liquid Chromatography

Inhibitory Effects of Various Ratios of Polysaccharides/Alkaloids from Rhizome of Coptis chinensis Franch on α-Glucosidase

Integrated metabolomics and ligand fishing approaches to screen the hypoglycemic ingredients from four Coptis medicines

Pharmacokinetics of Berberine,palmatine,coptisine,epiberberine and Jatrorr-Hizine from Coptidis Rhizoma in Diabetic Rats

Synthesis and in Vitro Glucose-Lowering Effect of 8-Alkyl-coptisine

Hypoglycemic and Hypocholesterolemic Effects of Coptis chinensis Franch Inflorescence

Impact of Preparative Isolation of C-Glycosylflavones Derived from Dianthus Superbus on in Vitro Glucose Metabolism.